SEC Form 4 · accession 0001274644-16-000143
Ocera Therapeutics, Inc. · OCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Willard H Dere
Director
Period of report
Oct 26, 2016
Accepted (ET)
Oct 28, 2016 · 9:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274644
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $2.42 | Oct 26, 2016 | A | 20,000 | A | — | Oct 25, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Option to purchase Common Stock granted by the Issuer pursuant to the Issuer's Fourth Amended and Restated 2011 Stock Option and Incentive Plan (the "Plan"), qualified under Rule 16b-3(d).
- F2The option shall vest and become exercisable with respect to 25% of the shares covered by the grant on October 26, 2016, subject to the Reporting Person's continued service to the Issuer through such date, with the balance to vest in equal monthly installments over the next succeeding three year period, subject to the Reporting Person's continued service to the Issuer through each such date.